Treatment-related problems in neonates receiving parenteral nutrition: risk factors and implications for practice.
The aim is to assess factors affecting treatment-related problems in neonatal patients receiving parenteral nutrition.
The aim is to assess factors affecting treatment-related problems in neonatal patients receiving parenteral nutrition.
The aim of the study was to study the use of enteral, parenteral nutrition, and oral nutritional supplements in ward patients with and without a previous ICU stay.
A retrospective analysis of >1500 patients with hematologic malignancies was undertaken to evaluate the association of parenteral nutrition administration with risk of central line–associated bloodstream infection.
Analysis of the relative impact of parenteral nutrition on liver dysfunction in critically ill patients, characterizing the presence of pre-existing liver disturbances, acute heart failure, sepsis, daily parenteral nutrition volume, and commonly used hepatotoxic drugs in adult ICU patients, together with daily aspartate aminotransferase, alanine aminotransferase, gamma-glutamyltransferase, alkalic phosphatase, total bilirubin, and INR values.
The review summarizes the most recent evidence relevant to clinical practice on selected aspects of medical nutrition therapy in adult patients in the intensive care unit and to provide guidance for implementing evidence-based approaches for adequate energy and nutrient supply in the intensive care unit setting.
Malnutrition and loss of muscle mass are common in patients who are admitted to intensive care units and are prognostic for negative outcomes including complications and mortality.
Investigation whether early nutrition is associated with clinical outcomes in neurocritically ill patients.
This study defines the existing barriers for early enteral nutrition in critically ill children and to analyzes the differences in nutrient supply, complications, and outcomes between early enteral nutrition and late enteral nutrition.
This study aimed to investigate the reasons, frequency, and duration of enteral nutrition interruptions in critically ill patients within the first seven days of ICU stay.
The aim of this review was to examine the effect of a commonly used immunomodulatory formula on clinical outcomes and mortality risk in critically ill patients.